Cargando…
Erratum: Vitexin Inhibits Gastric Cancer Growth and Metastasis through HMGB1-mediated Inactivation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway
Autores principales: | Zhou, Peng, Zheng, Zi-Han, Wan, Tao, Wu, Jie, Liao, Chuan-Wen, Sun, Xue-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Gastric Cancer Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091453/ https://www.ncbi.nlm.nih.gov/pubmed/35534452 http://dx.doi.org/10.5230/jgc.2022.22.e14 |
Ejemplares similares
-
Vitexin Inhibits Gastric Cancer Growth and Metastasis through HMGB1-mediated Inactivation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway
por: Zhou, Peng, et al.
Publicado: (2021) -
Erratum to: Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells
por: Befani, C. D., et al.
Publicado: (2013) -
Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum
por: Han, Fei, et al.
Publicado: (2020) -
PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum
por: Du, Peng, et al.
Publicado: (2022) -
Vitexin suppresses renal cell carcinoma by regulating mTOR pathways
por: Li, Yuhong, et al.
Publicado: (2020)